Free Trial

Avita Medical (RCEL) Competitors

Avita Medical logo
$5.17 -0.10 (-1.90%)
Closing price 04:00 PM Eastern
Extended Trading
$5.23 +0.06 (+1.24%)
As of 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RCEL vs. BVS, BFLY, KIDS, DCTH, AXGN, SMLR, TMCI, NPCE, OM, and CLPT

Should you be buying Avita Medical stock or one of its competitors? The main competitors of Avita Medical include Bioventus (BVS), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Delcath Systems (DCTH), AxoGen (AXGN), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), NeuroPace (NPCE), Outset Medical (OM), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry.

Avita Medical vs. Its Competitors

Bioventus (NYSE:BVS) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

62.9% of Bioventus shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 33.0% of Bioventus shares are held by insiders. Comparatively, 2.8% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Avita Medical has lower revenue, but higher earnings than Bioventus. Bioventus is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bioventus$567.70M0.99-$156.23M-$0.48-14.27
Avita Medical$64.25M2.13-$61.85M-$2.19-2.36

Bioventus presently has a consensus price target of $14.33, suggesting a potential upside of 109.25%. Avita Medical has a consensus price target of $16.50, suggesting a potential upside of 219.15%. Given Avita Medical's stronger consensus rating and higher possible upside, analysts plainly believe Avita Medical is more favorable than Bioventus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioventus
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Avita Medical
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Bioventus has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.52, suggesting that its share price is 52% more volatile than the S&P 500.

In the previous week, Avita Medical had 1 more articles in the media than Bioventus. MarketBeat recorded 2 mentions for Avita Medical and 1 mentions for Bioventus. Bioventus' average media sentiment score of 1.11 beat Avita Medical's score of 0.62 indicating that Bioventus is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bioventus
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avita Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bioventus has a net margin of -7.11% compared to Avita Medical's net margin of -79.61%. Bioventus' return on equity of 15.61% beat Avita Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Bioventus-7.11% 15.61% 4.01%
Avita Medical -79.61%-632.62%-71.72%

Summary

Bioventus and Avita Medical tied by winning 8 of the 16 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCEL vs. The Competition

MetricAvita MedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$139.31M$2.42B$5.54B$8.87B
Dividend YieldN/A1.77%5.39%4.10%
P/E Ratio-2.368.7226.1719.90
Price / Sales2.13663.86414.67113.66
Price / CashN/A151.5836.1356.90
Price / Book30.414.548.055.38
Net Income-$61.85M$31.16M$3.15B$248.50M
7 Day Performance8.39%0.15%1.85%2.97%
1 Month Performance-14.40%8.81%4.81%6.02%
1 Year Performance-34.39%2.55%34.86%20.39%

Avita Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCEL
Avita Medical
1.1277 of 5 stars
$5.17
-1.9%
$16.50
+219.1%
-31.7%$139.31M$64.25M-2.36130
BVS
Bioventus
3.3926 of 5 stars
$6.52
-0.5%
$14.33
+119.8%
+21.6%$535.58M$567.70M-10.691,200Positive News
BFLY
Butterfly Network
2.2104 of 5 stars
$2.05
-1.4%
$4.00
+95.1%
+118.5%$514.36M$82.06M-7.07460News Coverage
Analyst Forecast
KIDS
OrthoPediatrics
4.2374 of 5 stars
$20.59
+1.5%
$35.83
+74.0%
-22.5%$492.77M$204.73M-11.77200
DCTH
Delcath Systems
3.6145 of 5 stars
$13.26
-4.3%
$24.00
+81.0%
+54.5%$482.34M$37.21M-26.5260Gap Down
AXGN
AxoGen
2.6976 of 5 stars
$9.79
+0.6%
$22.20
+126.8%
+42.2%$443.14M$187.34M-65.26450Positive News
SMLR
Semler Scientific
2.3008 of 5 stars
$41.99
+16.2%
$71.00
+69.1%
+5.0%$403.02M$56.29M-16.09120Gap Up
High Trading Volume
TMCI
Treace Medical Concepts
2.5924 of 5 stars
$5.74
+4.2%
$10.16
+77.0%
-7.2%$346.52M$209.36M-6.75250
NPCE
NeuroPace
3.2631 of 5 stars
$10.57
+1.5%
$15.50
+46.6%
+43.2%$341.43M$79.91M-12.58170High Trading Volume
OM
Outset Medical
1.6856 of 5 stars
$17.37
-8.5%
$27.00
+55.4%
-62.5%$336.37M$113.69M-0.60520News Coverage
High Trading Volume
CLPT
ClearPoint Neuro
2.2883 of 5 stars
$11.36
+0.9%
$25.00
+120.1%
+111.3%$315.16M$31.39M-14.95110Positive News

Related Companies and Tools


This page (NASDAQ:RCEL) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners